Sodium hydride → HCID 68614327, compound

HRID 2240177Notes

Reaction equation

C([C:3]1[C:11]2[C:6](=[CH:7][C:8](C3N(C4C=CC(S(C)(=O)=O)=CC=4)N=CC=3)=[CH:9][CH:10]=2)[NH:5][N:4]=1)C.[H-].[Na+].I[CH:30]1[CH2:35][CH2:34][O:33][CH2:32][CH2:31]1>CN(C)C=O>[NH:5]1[C:6]2[C:11](=[CH:10][CH:9]=[CH:8][CH:7]=2)[CH:3]=[N:4]1.[O:33]1[CH2:34][CH2:35][CH2:30][CH2:31][CH2:32]1

Participants

Conditions

Temperature: 60 °C

Procedure

3-ethyl-6-{1-[4-(methylsulfonyl)phenyl]-1H-pyrazol-5-yl}-1H-indazole (0.18 g, 0.49 mmol) in N,N-dimethylformamide (6 mL) was added to a mixture of sodium hydride (29 mg, 60% in mineral oil, 0.74 mmol) and N,N-dimethylformamide (6 mL) under an atmosphere of argon, and the resulting mixture was stirred for 30 minutes. 4-iodotetrahydro-2H-pyran (0.16 g, 0.74 mmol) in N,N-dimethylformamide (6 mL) was then added and the reaction was heated at 60° C. for 50 hours. After cooling, the reaction mixture was concentrated and the residue diluted with water/acetonitrile (40 mL) and filtered (0.45 μm). The product was purified by preparative HPLC using a gradient of 20-80% acetonitrile:water (with 0.1% formic acid and a flow rate of 45 mL/min to afford 10 mg (4.6%) of 3-ethyl-6-{1-[4-methylsulfonyl)phenyl]-1H-pyrazol-5-yl}-1 (tetrahydro-2H-pyran)-1H-indazole as a yellow solid. LC/MS (EI) tR 4.54 (Method A), m/z 451.2 (M++1). 1H NMR (CDCl3) δ 1.4 (t, 3H); 1.9 (d, 2H); 2.4 (m, 2H); 3.0 (m, 1H); 3.1 (s, 3H); 3.6 (m, 3H); 4.1 (d, 2H); 4.5 (m, 1H); 6.6 (s, 1H); 6.9 (d, 1H); 7.2-7.3 (m, 3H); 7.5-7.7 (m, 2H); 7.8-7.9 (m, 2H).

Workup

temperatureAfter cooling
concentrationthe reaction mixture was concentrated
additionthe residue diluted with water/acetonitrile (40 mL)
filtrationfiltered (0.45 μm)
customThe product was purified by preparative HPLC

Sources & evidence

ORD record: ord-b1f1227fc18540158f5c8a324eb00864
Source dataset: uspto-grants-2010_05
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US07723348B2

Reaction notes

Loading…